Gunderson Dettmer advised Natera, Inc. in a follow-on public offering of 5,175,000 shares at the price to the public of $20.00 per share for a total of $103,500,000 in aggregate gross proceeds.
The underwriting syndicate included J.P. Morgan, Morgan Stanley and Cowen.
Natera, which trades on the Nasdaq under the ticker symbol “NTRA,” is a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA. The company, led by Matthew Rabinowitz,
Steve Chapman and Jonathan Sheena in 2017 recoreded $210 Million Revenues.
Gunderson Dettmer advised Natera with a team including Richard Blake (Picture), Heidi Mayon, John Dietz, Owais Mahesri and Cathy Kwon.
Law Firms: Gunderson Dettmer;
Clients: Natera, Inc.;